In the News

Share

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

1749 News Items found
Man in his 70s (prostate cancer patient) smiling for camera
FDA Expands New Treatment for Prostate Cancer: Targets a Protein Called PSMA

Learn more about a new radiopharmaceutical treatment for prostate cancer approved by the FDA for more patients.
Steve and Sara Harrold smiling and holding hands on a couch in Hope Lodge
Throat Cancer Treatment at MSK, Thanks to an Employer’s Cancer Care Benefits

Learn how MSK Direct — one of the nation's largest employer cancer benefits programs — made it easier for Steve Harrold to travel from Massachusetts to MSK for treatment days after a throat cancer diagnosis.
A researcher working in an MSK lab
MSK Research Highlights, March 26, 2025

New MSK research develops a new tool for studying mitochondrial DNA deletions; uncovers mechanisms of histiocytosis-associated neurodegeneration; and investigates how mutant stem cells co-opt regeneration to make tumors grow.
Alexandra Joyner
Looking Back, Looking Ahead With MSK Developmental Biologist Alexandra Joyner

Developmental biologist Dr. Alexandra Joyner reflects on her career and talks about the new passions she looks forward to pursuing in retirement.
In the Clinic
Illustration of brain in green with pons area highlighted in orange.
Latest Research Into DIPG Pediatric Brain Cancer Treatment Using Novel Drug Delivery Technique

A new drug delivery method could improve treatment of a lethal pediatric brain tumor called diffuse intrinsic pontine glioma.
Q&A
T lymphocytes attached to a cancer cell
The Immune System and Cancer Vaccines

Learn how MSK researchers are trying to understand how the immune system senses cancer in order to make better immunotherapies.
Feature
Group photo of the winners of the 2025 Kravis WiSE fellowships in a lab at the Sloan Kettering Institute
Meet the Winners of the 2025 Kravis WiSE Fellowships

MSK is proud to announce that four Sloan Kettering Institute (SKI) researchers have been named 2025 Marie-Josée Kravis Women in Science Endeavor (Kravis WiSE) fellowship grant recipients.
Advanced lung cancer patient Giancarlo Oviedo-Mori watches the sun set over the water with his 2-year-old son.
How One Young Adult With Stage 4 Lung Cancer Is Beating the Odds

Learn how new research and clinical trials at Memorial Sloan Kettering Cancer Center (MSK) have helped 32-year-old Giancarlo Oviedo-Mori survive — and thrive — with advanced lung cancer for 15 years.
Dr. Raajit Rampal
Promising New Treatment for Myelofibrosis Blood Cancer Using a Combination Targeted Therapy 

A phase 3 trial for myelofibrosis found that adding pelebresib to ruxolitinib was more effective than ruxolitinib alone and did not significantly increase side effects.
Scientific figure showing DNA replication stalled out at a G-quadruplex
Cryo-Electron Microscopy Reveals Hidden Mechanics of DNA Replication, Sheds New Light on Cancer Target

MSK researchers shed new light on G-quadruplexes, a type of secondary DNA structure that has attracted attention as a potential therapeutic target in cancer.